Christopher Mutz - 07 Mar 2023 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
HEAD OF RARE DISEASE
Signature
/s/ Christopher Mutz
Issuer symbol
ANIP
Transactions as of
07 Mar 2023
Net transactions value
-$84,125
Form type
4
Filing time
09 Mar 2023, 17:48:05 UTC
Previous filing
04 Apr 2023
Next filing
13 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Tax liability $63,072 -1,426 -3.6% $44.23 38,136 07 Mar 2023 Direct F1
transaction ANIP Common Stock Tax liability $21,053 -476 -1.2% $44.23 37,660 07 Mar 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,857 shares of restricted stock, the grant of which was previously reported.
F2 Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,619 shares of restricted stock, the grant of which was previously reported.